NEXALIS THERAPEUTICS LTD — Proxy Solicitation & Information Statement 2025

Dec 23, 2025

==> picture [229 x 46] intentionally omitted <==

24 December 2025

General Meeting

Dear Shareholder,

The Board of InhaleRx Limited ACN 611 845 820 (ASX: IRX) (the Company ) advises shareholders it will be convening a General Meeting ( Meeting ) at 4.00pm Australian Eastern Daylight Time ( AEDT ) on Thursday, 29 January 2026.

The Meeting will be an online-only meeting. Shareholders attending online will be able to watch, listen, ask questions and vote online. Online attendees are encouraged to pre-register as far in advance of the day of the Meeting as practical:

https://us02web.zoom.us/webinar/register/WN_UCOxe6qkTC2ejUXxdYdtEw

Shareholders are strongly encouraged to lodge their proxy votes by 4.00pm AEDT on Tuesday, 27 January 2026 ( Proxy Deadline ) and in accordance with the instructions set out on the Proxy Form that accompanies this letter.

In accordance with section 110D of the Corporations Act 2001 (Cth) (as inserted by the Corporations Amendment (Meetings and Documents) Act 2022 (Cth)), the Company will not be dispatching physical copies of the Notice of Meeting and Explanatory Statement ( Notice ), instead a copy of the Notice is available for download from:

• The Company’s share registry, Automic; or

• The IRX Company Information page on ASX.

The resolutions will be decided by way of a Poll. If you are unable to attend the Meeting, you may wish to email any questions you want addressed at the Meeting by emailing them to james.barrie@inhalerx.com.au by 5.00pm AEDT on Thursday, 22 January 2026.

The Board look forward to welcoming you to the Meeting.

Yours faithfully

==> picture [241 x 58] intentionally omitted <==

James Barrie Company Secretary